Video

The NAMS Revolution: Why Now?

Source: Drug Discovery Online

Zaher frames the urgency of NAMS adoption by highlighting the staggering 92% drug failure rate in clinical trials despite animal testing. He explains how interdisciplinary convergence and AI are accelerating the shift toward human-relevant models, positioning NAMS as a solution to systemic inefficiencies in drug development.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Please tell us more about you so that we can customize our newsletters to your specific interests: